gory, as described later. All literature (e.g., randomized controlled trials, observational studies, and case reports) relevant to each topic was considered when evaluating the findings. For reporting purposes in this document, only the highest level of evidence (i.e., levels 1, 2, or 3 identified below) within each category (i.e., A, B, or C) is included in the summary.
Category A: Supportive Literature
Randomized controlled trials report statistically significant (P Ͻ 0.01) differences among clinical interventions for a specified clinical outcome.
Level 1: The literature contains multiple, randomized controlled trials, and the aggregated findings are supported by meta-analysis. ‡ Level 2: The literature contains multiple, randomized controlled trials, but there is an insufficient number of studies to conduct a viable meta-analysis for the purpose of this Advisory. Level 3: The literature contains a single randomized controlled trial.
Category B: Suggestive Literature
Information from observational studies permits inference of beneficial or harmful relationships among clinical interventions and clinical outcomes.
Level 1: The literature contains observational comparisons (e.g., cohort and case-control research designs) of clinical interventions or conditions and indicates statistically significant differences between clinical interventions for a specified clinical outcome. Level 2: The literature contains noncomparative observational studies with associative (e.g., relative risk and correlation) or descriptive statistics. Level 3: The literature contains case reports.
Category C: Equivocal Literature
The literature cannot determine whether there are beneficial or harmful relationships among clinical interventions and clinical outcomes.
Level 1: Meta-analysis did not find significant differences among groups or conditions. Level 2: There is an insufficient number of studies to conduct meta-analysis, and (1) randomized controlled trials have not found significant differences among groups or conditions or (2) randomized controlled trials report inconsistent findings. Level 3: Observational studies report inconsistent findings or do not permit inference of beneficial or harmful relationships.
Category D: Insufficient Evidence from Literature
The lack of scientific evidence in the literature is described by the following conditions: (1) No identified studies address the specified relationships among interventions and outcomes.
(2) The available literature cannot be used to assess relationships among clinical interventions and clinical outcomes. The literature either does not meet the criteria for content as defined in the Focus of the Advisory or does not permit a clear interpretation of findings due to methodologic concerns (i.e., confounding in study design or implementation).
Opinion-based Evidence
All opinion-based evidence relevant to each topic (e.g., survey data, open-forum testimony, Internet-based comments, letters, and editorials) is considered in the development of this Advisory. However, only the findings obtained from formal surveys are reported. Opinion surveys were developed by the Task Force to address each clinical intervention identified in the document. Identical surveys were distributed to two groups of respondents: expert consultants and ASA members.
Category A: Expert Opinion
Survey responses from Task Force-appointed expert consultants are reported in summary form in the text. A complete listing of consultant survey responses is reported in a table in appendix 2.
Category B: Membership Opinion
Survey responses from a random sample of members of the ASA are reported in summary form in the text. A complete listing of ASA member survey responses is reported in a table in appendix 2.
Expert consultant and ASA membership survey responses are recorded using a five-point scale and summarized based on median values. § Strongly agree: Median score of 5 (at least 50% of the responses are 5). Agree: Median score of 4 (at least 50% of the responses are 4 or 4 and 5). Equivocal: Median score of 3 (at least 50% of the responses are 3, or no other response category or combination of similar categories contain at least 50% of the responses). Disagree: Median score of 2 (at least 50% of responses are 2 or 1 and 2). Strongly disagree: Median score of 1 (at least 50% of responses are 1).
Category C: Informal Opinion
Open-forum testimony, Internet-based comments, letters, and editorials are all informally evaluated and discussed during the development of the Advisory. When warranted, the Task Force may add educational information or cautionary notes based on this information.
Advisories

I. Prevention of Infectious Complications Associated with Neuraxial Techniques
Topics addressed with regard to the prevention of infectious complications related to neuraxial techniques are as follows:
(1) conducting a history, physical examination, and preprocedure laboratory evaluation; (2) use and selection of neuraxial technique; (3) prophylactic antibiotic therapy; (4) use of aseptic techniques; (5) selection of antiseptic solution; (6) use of sterile occlusive dressings at the catheter insertion site; (7) use of a bacterial filter during continuous epidural infusion; (8) limiting disconnection and reconnection of neuraxial delivery systems; (9) management of an accidentally disconnected catheter; and (10) limiting the duration of catheterization. Advisory statements for the above topics are reported below after descriptions of the evidence for all 10 topics. History, physical examination, and preprocedure laboratory evaluation: Although no controlled trials were found that addressed the impact of conducting a focused history (e.g., reviewing medical records), a physical examination or a preprocedure laboratory evaluation, several studies with observational findings suggest that certain patient or clinical characteristics (e.g., cancer, diabetes, and impaired immune response) may be associated with neuraxial-related infections (Category B2 evidence). [1] [2] [3] [4] [5] [6] [7] [8] [9] In addition, case reports indicate that conditions such as preexisting infections, pancreatitis, gastrointestinal bleeding, drug, or alcohol abuse may also be associated with neuraxial-related infections (Category B3 evidence).
-30
Both consultants and ASA members strongly agree that history, physical examination, and review of relevant laboratory studies should be conducted before performing neuraxial techniques. Consultants agree and ASA members strongly agree that history, physical examination, and review of relevant laboratory studies are useful in identifying patients at increased risk of infectious complications before performing neuraxial techniques.
Use and selection of neuraxial technique:
The risk of developing infectious complications associated with specific neuraxial techniques is addressed by making the following comparisons: (1) epidural versus spinal techniques, (2) continuous infusion or catheter versus single injection techniques, (3) lumbar epidural versus thoracic epidural techniques, and (4) lumbar epidural versus caudal techniques.
No randomized controlled trials were found that reported differences between specific neuraxial techniques regarding infectious complications (Category D evidence). One nonrandomized comparative study reports no significant differences in bacterial contamination of needles when epidural lumbar puncture is compared with spinal lumbar puncture (Category C2 evidence). 31 The literature is insufficient to evaluate differences in infectious complications between continuous in- § When an equal number of categorically distinct responses are obtained, the median value is determined by calculating the arithmetic mean of the two middle values. Ties are calculated by a predetermined formula.
fusion or catheter and single injection techniques (Category D evidence). One case-control study reports no differences in epidural catheter infections when the lumbar insertion technique is compared with the thoracic insertion technique (Category C3 evidence).
32 Three nonrandomized comparative studies report no statistically significant (P Ͼ 0.01) differences in bacterial colonization of the catheter tip when the lumbar insertion site is compared with the caudal insertion site (Category C3 evidence).
33-35
Both consultants and ASA members strongly agree that, for patients determined to be at risk of infectious complications, the decision to select a neuraxial technique should be determined on a case-by-case basis. Consultants agree and ASA members strongly agree that, for these patients, alternatives to neuraxial techniques should be considered. Moreover, both consultants and ASA members strongly agree that the evolving medical status of the patient should be considered in the selection of neuraxial technique. Both consultants and ASA members strongly agree that a lumbar puncture should be avoided in a patient with a known epidural abscess.
Prophylactic antibiotic therapy:
The literature is insufficient to assess whether prophylactic antibiotic therapy reduces the risk of infectious complications associated with neuraxial techniques (Category D evidence). Case reports indicate that infectious complications may occur even when prophylactic antibiotic therapy is administered (Category B3 evidence).
10,36,37
Both consultants and ASA members strongly agree that, when a neuraxial technique is selected in a known or suspected bacteremic patient, preprocedure antibiotic therapy should be administered.
Use of aseptic techniques:
The literature is insufficient regarding the efficacy of aseptic techniques during neuraxial procedures (e.g., removal of jewelry, hand washing, and wearing of caps, masks, and sterile gloves) in reducing infectious complications (Category D evidence). Studies with observational findings indicate that infections occur even when aseptic techniques are used (Category B2 evidence), 38 -40 and case reports indicate similar outcomes (Category B3 evidence). 12, 19, [25] [26] [27] 30, The literature is insufficient regarding the choice of specific antiseptic solutions in reducing infectious complications associated with neuraxial techniques (Category D evidence). However, two randomized controlled trials indicate that the rate of positive bacteriologic cultures is reduced when the patient's skin is prepared with chlorhexidine compared with povidone-iodine before epidural catheterization (Category A2 evidence).
65,66 Two randomized controlled trials report reduced bacterial growth on the skin and/or on catheters and needles when alcohol is combined with povidone-iodine compared with povidone-iodine alone (Category A2 evidence).
66,67
Both consultants and ASA members strongly agree that aseptic techniques should always be used during the placement of neuraxial needles and catheters, including hand washing, wearing of sterile gloves, wearing of caps, wearing of masks covering both the mouth and nose, use of individual packets of skin preparation, and sterile draping of the patient. In addition, both consultants and ASA members agree that aseptic techniques should include removal of jewelry, and they are equivocal regarding the wearing of gowns. Finally, consultants agree and ASA members are uncertain regarding whether aseptic techniques should include changing masks before each new case.
Selection of antiseptic solution: Although the literature is insufficient regarding whether the use of individual antiseptic packets compared with multiple-use bottles of antiseptic reduces infectious complications (Category D evidence), one observational study indicates that microbial contamination occurs when previously opened multiple-use bottles of povidone-iodine are used compared with no contamination with the use of unopened multiple-use bottles (Category B1 evidence) . 68 Further, one case report indicates lumbar spondylodiscitis occurring in a patient whose skin was cleansed with povidone-iodine obtained from a multiple-use bottle (Category B3 evidence).
51
The consultants indicate a preference for chlorhexidine with alcohol as a skin preparation solution before performing a neuraxial technique, whereas the ASA members indicate no clear preference among chlorhexidine with or without alcohol or povidone-iodine with or without alcohol.
Use of sterile occlusive dressings at the catheter insertion site: No comparative studies were found that indicates whether the use of sterile occlusive dressings at the catheter insertion site reduces infectious complications (Category D evidence). One observational study reports positive cultures in more than 30% of catheter tips (Category B2 evidence).
69 Four case reports indicate that skin or epidural abscesses can occur when occlusive dressings are used (Category B3 evidence). 27, 52, 70, 71 Both consultants and ASA members strongly agree that sterile occlusive dressings should be used at the catheter insertion site.
Use of a bacterial filter during continuous epidural infusion: No comparative studies were found that indicates whether the use of bacterial filters reduce infectious complications (Category D evidence). One nonrandomized comparative study found that the use of a bacterial filter during continuous epidural infusion does not reduce the number of positive cultures distal to the filter (Category C2 evidence).
72 Three studies with observational findings indicate that infections and epidural abscesses can occur in the presence of micropore filters (Category B2 evidence). 38, 69, 73 ASA members agree and consultants are uncertain regarding whether bacterial filters should be used during continuous epidural infusion.
Limiting disconnection and reconnection of neuraxial delivery systems: The literature is insufficient to evaluate whether limiting disconnection and reconnection of neuraxial delivery systems are associated with reduced frequency of infectious complications (Category D evidence).
Both consultants and ASA members strongly agree that disconnection and reconnection of neuraxial delivery systems should be limited to minimize the risk of infectious complications.
Management of an accidentally disconnected catheter:
The literature is insufficient to evaluate whether removal of an accidentally disconnected catheter is associated with reduced frequency of infectious complications (Category D evidence).
ASA members are equivocal, and consultants disagree that accidentally disconnected catheters should be immediately removed. However, the Task Force believes that, to avoid infectious complications, an unwitnessed accidentally disconnected catheter should be removed.
Limiting 
Advisory Statements for Prevention
History and physical examination relevant to the procedure and review of relevant laboratory studies should be conducted to identify patients who may be at risk of infectious complications before performing neuraxial techniques. Consider alternatives to neuraxial techniques for patients at high risk. When neuraxial techniques are selected in a known or suspected bacteremic patient, consider administering preprocedure antibiotic therapy. Selection of neuraxial technique should be determined on a case-by-case basis, including consideration of the evolving medical status of the patient. Lumbar puncture should be avoided in the patient with a known epidural abscess.
Aseptic techniques should always be used during preparation of equipment (e.g., ultrasound) and the placement of neuraxial needles and catheters, including (1) removal of jewelry (e.g., rings and watches), hand washing, and wearing of caps, masks (covering both mouth and nose and consider changing before each new case), and sterile gloves; (2) use of individual packets of antiseptics for skin preparation; (3) use of chlorhexidine (preferably with alcohol) for skin preparation, allowing for adequate drying time#; (4) sterile draping of the patient; and (5) use of sterile occlusive dressings at the catheter insertion site.** Bacterial filters may be considered during extended continuous epidural infusion. Limit the disconnection and reconnection of neuraxial delivery systems to minimize the risk of infectious complications. Consider removing unwitnessed accidentally disconnected catheters. Finally, catheters should not remain in situ longer than clinically necessary.
II. Diagnosis of Infectious Complications Associated with Neuraxial Techniques
Topics addressed with regard to the diagnosis of infectious complications consists of (1) periodically checking for signs or symptoms of infection (e.g., erythema, tenderness, and fever), (2) ordering blood tests (e.g., leukocyte count, sedimentation rate, and C-reactive protein), (3) ordering a culture or cerebrospinal fluid analysis, (4) ordering imaging studies (magnetic resonance imaging, computed tomography, and myelography), and (5) periodically checking patients' neurologic function. Advisory statements for the above topics are reported below after descriptions of the evidence for all five topics.
Periodically checking for signs or symptoms of infection: Studies with observational findings and case reports indicate that early signs and symptoms (e.g., fever, backache, headache, erythema, and tenderness at the insertion site) may be associated with the onset of infectious complications, and additional symptoms (e.g., stiff neck, photophobia, radiating pain, loss of motor function, and confusion) may indicate further development of the infectious complication (Category B2-B3 evidence).
2,4,7,10 -30,36,37,41-58,60,62-64,69,70,80 -82,84-86,89 -157 The Task Force notes that signs or symptoms can either manifest within a few hours or may not be apparent for weeks after neuraxial administration.
Both consultants and ASA members strongly agree that periodic evaluation of patients for signs and symptoms (e.g., fever, headache, backache, erythema, and tenderness at the insertion site) is essential for the early identification of infectious complications. They agree that signs and symptoms should be assessed once per day and strongly agree that signs and symptoms should be promptly attended to minimize the impact of an infectious complication. Finally, they strongly agree that, if an infection is suspected, an in situ catheter should be immediately removed.
Ordering blood tests: Numerous case reports indicate that blood tests (e.g., leukocyte counts, sedimentation rates, and C-reactive protein) may be useful in identifying infection (Category B3 evidence). Both consultants and ASA members agree that, if an infection is suspected, blood tests should be ordered.
Ordering, conducting, or requiring routine laboratory studies may not be necessary.
# When chlorhexidine is not available, use of povidone-iodine with alcohol is preferred over povidone-iodine alone. Consult product labels for instructions regarding the proper use, application, and drying time for skin antiseptics. Both consultants and ASA members strongly agree that, if an infection is suspected, the catheter tip should be cultured. In addition, they agree that additional cultures should be obtained.
Ordering imaging studies: Studies with observational findings and case reports indicate that conducting a magnetic resonance imaging, computed tomography, or myelogram is useful in identifying infectious complications (e.g., epidural abscess, discitis, and osteomyelitis) (Category B2-B3 evidence). Both consultants and ASA members strongly agree that, if an abscess is suspected or neurologic deficit is present, consultation with other appropriate specialties should be promptly obtained.
Advisory Statements for Diagnosis
Daily evaluation of patients with indwelling catheters for early signs and symptoms (e.g., fever, backache, headache, erythema, and tenderness at the insertion site) of infectious complications should be performed throughout their stay in the facility. † † To minimize the impact of an infectious complication, promptly attend to signs or symptoms. If an infection is suspected: (1) remove an in situ catheter and consider culturing the catheter tip, (2) order appropriate blood tests, (3) obtain appropriate cultures, and (4) if an abscess is suspected or neurologic dysfunction is present, imaging studies should be performed and consultation with other appropriate specialties should be promptly obtained.
III. Management of Infectious Complications
Topics addressed with regard to management or treatment of infectious complications includes (1) administration of antibiotics, (2) consultation with appropriate specialists to determine optimal nonsurgical treatment, and (3) Both consultants and ASA members strongly agree that appropriate antibiotic therapy should always be administered at the earliest sign or symptom of a serious infection.
Collaboration with appropriate medical specialists to determine optimal nonsurgical treatment: The literature is insufficient to evaluate the impact of collaboration with appropriate medical specialists on outcome (Category D evidence). The Task Force believes that appropriate antibiotic therapy should always be administered at the earliest sign or symptom of a serious infection, and consultation with a physician with expertise in the diagnosis and treatment of infectious diseases should be considered. However, the Task Force recognizes that even with prompt medical intervention, recovery may be poor or incomplete.
The consultants agree and ASA members strongly agree that a specialist or physician with expertise in the diagnosis and treatment of infectious diseases should be consulted at the first sign of a serious infection.
Collaboration with a surgeon to determine whether surgical intervention is warranted: No controlled studies were found that reported differences in neurologic outcome associated with either percutaneous drainage or surgical interventions (Category D evidence). Case reports indicate that percutaneous drainage of an abscess may be effective in the resolution of symptoms (Category B3 evidence). 11, 83, 148 Case reports indicate that surgical interventions (e.g., surgical drainage of an abscess, debridement, and laminectomy) for an abscess may be effective and can result in improved neurologic function, although in some cases motor or sensory deficits may persist (Category B3 evidence). Both consultants and ASA members strongly agree that, if an abscess is present, surgical consultation should be obtained to determine whether percutaneous drainage of the abscess or surgery (e.g., laminectomy) is warranted.
Advisory Statements for Management
Appropriate antibiotic therapy should always be administered at the earliest sign or symptom of a serious neuraxial infection. Consultation with a physician with expertise in the diagnosis and treatment of infectious diseases should be considered. If an abscess is present, surgical consultation should be obtained to determine whether percutaneous drainage of the abscess or surgery (e.g., laminectomy) is warranted. • When neuraxial techniques are selected in a known or suspected bacteremic patient, consider administering preprocedure antibiotic therapy.
• Selection of neuraxial technique should be determined on a case-by-case basis, including consideration of the evolving medical status of the patient.
• Lumbar puncture should be avoided in the patient with a known epidural abscess.
• Aseptic techniques should always be used during the preparation of equipment (e.g., ultrasound) and the placement of neuraxial needles and catheters, including the following:
• Removal of jewelry (e.g., rings and watches), hand washing, and wearing of caps, masks (covering both mouth and nose and consider changing before each new case), and sterile gloves.
• Use of individual packets of antiseptics for skin preparation.
• Use of chlorhexidine (preferably with alcohol) for skin preparation, allowing for adequate drying time. § §
• Sterile draping of the patient.
• Use of sterile occlusive dressings at the catheter insertion site.
• Bacterial filters may be considered during extended continuous epidural infusion.
• Limit the disconnection and reconnection of neuraxial delivery systems to minimize the risk of infectious complications.
• Consider removing unwitnessed accidentally disconnected catheters.
• Catheters should not remain in situ longer than clinically necessary.
II. Diagnosis of Infectious Complications Associated with Neuraxial Techniques
• Daily evaluation of patients with indwelling catheters for early signs and symptoms (e.g., fever, backache, headache, erythema, and tenderness at the insertion site) of infectious complications should be performed throughout their stay in the facility.
• To minimize the impact of an infectious complication, promptly attend to signs or symptoms.
• If an infection is suspected:
• Remove an in situ catheter and consider culturing the catheter tip.
• Order appropriate blood tests.
• Obtain appropriate cultures.
• If an abscess is suspected or neurologic dysfunction is present, imaging studies should be performed and consultation with other appropriate specialties should be promptly obtained.
III. Management of Infectious Complications
• Appropriate antibiotic therapy should always be administered at the earliest sign or symptom of a serious neuraxial infection.
• Consultation with a physician with expertise in the diagnosis and treatment of infectious diseases should be considered.
• If an abscess is present, surgical consultation should be obtained to determine whether percutaneous drainage of the abscess or surgery (e.g., laminectomy) is warranted. • History (i.e., a focused review of medical records), physical examination, and patient interview to identify patients who may be at risk of infectious complications before neuraxial administration.
Appendix 2: Methods and Analyses
• Aseptic techniques during the placement or removal of neuraxial needles:
• Hand washing, wearing of sterile gloves, caps, masks and gowns, and sterile draping of the patient.
• Limiting the disconnection and reconnection of neuraxial delivery systems.
• Immediate removal of an accidentally disconnected catheter.
• Use of bacterial filters during continuous epidural infusion.
• Skin preparation:
• Chlorhexidine versus povidone-iodine.
• Skin preparation with versus without alcohol.
II. Diagnosis of infectious complications associated with neuraxial techniques.
• Signs and symptoms of an infection.
• Blood tests.
• Culture from either blood, cerebrospinal fluid, or discharge material from the insertion site.
• Neurologic function tests.
• Imaging studies (magnetic resonance imaging, computed tomography, and myelography).
III. Management of infectious complications.
• Antibiotic therapy.
• Consultation with appropriate specialists to determine optimal nonsurgical treatment.
• Surgical consultation on identification of an abscess.
For the literature review, potentially relevant studies were identified using electronic and manual searches of the literature. The literature search covered a 48-yr period from 1962 through 2009. Over 500 citations were initially identified, yielding a total of 420 articles that addressed topics related to the specific evidence linkages in this Advisory and potentially met our criteria for inclusion. After review of the articles, 232 studies did not provide direct evidence and were subsequently eliminated. A total of 188 articles contained direct § § When chlorhexidine is not available, use of povidone-iodine with alcohol is preferred over povidone-iodine alone. Consult product labels for instructions regarding the proper use, application and drying time for skin antiseptics.
Immunocompromised patients may not manifest typical signs and symptoms of infection.
## Unless otherwise specified, outcomes for the listed interventions refer to the occurrence of infectious complications. Interobserver agreement among Task Force members and two methodologists was established by interrater reliability testing. Agreement levels using a statistic for two-rater agreement pairs were as follows: (1) The consultants were asked to indicate which, if any, of the evidence linkages would change their clinical practices if the Advisory was instituted. The rate of return was 14% (n ϭ 17 of 119). The percent of responding consultants expecting a change in their practice associated with each linkage topic was as follows: (1) history and physical examination ϭ 5.9%; (2) use and selection of neuraxial techniques ϭ 5.9%; (3) aseptic techniques ϭ 41.2%; (4) disconnection and reconnection of catheters ϭ 23.5%; (5) duration of catheterization ϭ 6.9%; (6) checking for signs and symptoms of an infectious complication ϭ 5.9%; (7) use of antibiotics ϭ 5.9%; and (8) consultation with other specialists ϭ 5.9%. Eighty-eight percent of the respondents indicated that the Advisory would have no effect on the amount of time spent on a typical case, and 11.8% indicated an average increase of 2.8 min in the amount of time expected to spend on a typical case with the implementation of this Advisory. Eighty-two percent indicated that new equipment, supplies, or training would not be needed to implement the guidelines, and 76.4% indicated that implementation of the guidelines would not require changes in practice that would affect costs. 
